Form 4 Filing for John F. Milligan

John F. Milligan, a director at 4D Molecular Therapeutics, Inc. (FDMT), was granted 75,000 stock options on June 17, 2026. The options, which have an exercise price of $9.42, were automatically granted under the company's non-employee director compensation program. These options vest over three years, with 1/3 vesting on June 17, 2027, and the remainder vesting in equal monthly installments thereafter, contingent upon continued service. Full vesting occurs upon a Change in Control. The options expire on June 16, 2036. Milligan reported direct ownership of these options following the transaction.